Stefano Barlati, MD is an expert in Psychiatry at University of Brescia (Italy). Stefano Barlati has authored 181 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 606 (community average: 125). How the SLR is computed.

LeadR Profile

Stefano Barlati, MD University of Brescia Italy
606 ScienceLeadR Reputation 606
Network Map

Psychiatry

Subspecialties: Neurology - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026

Source: PubMed

University of Brescia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 181

Citations

Citations: 5 073 1st author: 24 Last author: 12 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Reply to Letter to the Editor: Methodological considerations regarding confirmatory claims and multiple comparisons in the PANDORA trial symptom-remission analysis.
PMID 42934024 — psychiatry
J Psychiatr Res20260
Dropout from individual cognitive behavioral psychotherapy for schizophrenia: a systematic review and meta-analysis of randomized clinical trials.
PMID 42856083 — patient dropouts, psychotherapy, schizophrenia, therapeutics, outpatients, cognitive behavioral therapy
Nord J Psychiatry20260
Advances in non-invasive brain stimulation for borderline personality disorder: clinical targets and future directions - an updated narrative review.
PMID 42632061 — personality disorders, transcranial direct current stimulation, borderline personality disorder, personality, emotions, biological psychiatry, brain, psychotherapy, transcranial magnetic stimulation, prefrontal cortex, therapeutics, impulsive behavior
World J Biol Psychiatry20260
Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study.
PMID 42700488 — cohort studies, signs and symptoms, depressive disorder, depressive disorder, major, psychiatry
Psychiatry Res20260
Brain Stimulation for Psychiatric Disorders: Emerging Evidence and New Perspectives-2nd Edition.
PMID 42512500 — mental disorders, brain
Brain Sci20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4

By status:

Recruiting 2
Completed 1
Unknown 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effectiveness of EMDR in Borderline Personality Disorder
NCT06493708 — eye, personality disorders, stress disorders, post-traumatic, borderline personality disorder, personality, eye movement desensitization reprocessing, case-control studies, psychotherapy, eye movements, stress disorders, traumatic, therapeutics, wounds and injuries, movement
N/ARecruiting2024

LeadR Networks

Main global connection map